Author Archives: Kristy Ainslie
Some SciComm at Scroggs Elementary of Phases of Mater
Great time doing some #scicomm on Phases of Matter at Scroggs Elementary. How can you go wrong freezing things in liquid nitrogen and using dry ice to make soap bubbles!?
Liz and Rebeca at Women in Science Poster Session
Grad student Rebeca Stiepel and post doc Dr. Elizabeth Gurysh at UNC_TIBBS Women In Science Spring Symposium. Presenting our work on MultipleSclerosis and Glioblastoma therapies.
Kristy presents at SFB
Dr. Ainslie presented: Effects of Tunable Degradation on Humoral, Cellular, and Protective Immune Responses Generated by a Universal Flu Vaccine Formulated with Acetalated Dextran Microparticles, K. Ainslie*(1), N. Chen(2), M. Collier(3), M. Gallovic(4), J. Ting(1), E. Bachelder(1); (1)University of North … Read more
Dr. Gurysh receives an NIH F32
Ainslie’s Lab own Dr. Gurysh Receives NIH F32 Grant for Brain Cancer Research! Great work Liz! https://unc.live/2U8r2t1
New publication on Cancer Immunotherapy
New publication in Biomaterials “A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity” – https://bit.ly/2Oj5uVm . In collaboration with Jenny Ting in the Lineberger Cancer Center.
Dr. Ainslie to be NANO member
In fall of 2019, Dr. Ainslie will become a standing member of the NIH study section NANO.
Talk at UGA Center for Vaccines & Immunology.
The talk “Acetalated Dextran: a spoonful of sugar helps the medicine (and vaccine) go down!” was given to a group at UGA in the Center for Vaccines and Immunology in Athens, GA.